SPO11 AS MODIFIER OF THE P53 PATHWAY AND METHODS OF USE

Details for Australian Patent Application No. 2002310271 (hide)

Owner EXELIXIS, INC.

Inventors FRIEDMAN, Lori; PLOWMAN, Gregory, D.; BELVIN, Marcia; FRANCIS-LANG, Helen

Pub. Number AU-A-2002310271

PCT Number PCT/US02/17412

PCT Pub. Number WO2002/099046

Priority 60/357,253 15.02.02 US; 60/296,076 05.06.01 US; 60/328,605 10.10.01 US

Filing date 3 June 2002

Wipo publication date 16 December 2002

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 60/357,253 15.02.02 US; 60/296,076 05.06.01 US; 60/328,605 10.10.01 US

8 May 2003 Application Open to Public Inspection

  Published as AU-A-2002310271

11 March 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002310272-ALPHA 2 INTEGRIN: MODULATORS OF LYMPHOCYTE ACTIVATION

2002310270-HS2STs as modifiers of the p53 pathway and methods of use